The European Medicines Agency Discovers the Geriatric Patient

Author： Baeyens JP  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.28, Iss.11, 2011-11, pp. : 849-851

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulating medicines in Europe: the European Medicines Agency, marketing authorisation, transparency and pharmacovigilance

By Permanand Govin   Mossialos Elias   McKee Martin  

Clinical Medicine, Vol. 6, Iss. 1, 2006-01 ,pp. : 87-90

Royal College Of Physicians

Access to resources Recommend Favorite

The European Medicines Agency has announced they will be making important changes.

By  

Reactions Weekly, Vol. 1, Iss. 1282, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

European Medicines Agency provides weekly pandemic pharmacovigilance update

By  

Reactions Weekly, Vol. 1, Iss. 1282, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The European Medicines Evaluation Agency: role of experts in drug assessment

By Benzi G.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 12, 1995-12 ,pp. : 409-412

Elsevier

Access to resources Recommend Favorite

Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years

By Ceci A.   Felisi M.   Baiardi P.   Bonifazi F.   Catapano M.   Giaquinto C.   Nicolosi A.   Sturkenboom M.   Neubert A.   Wong I.  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 11, 2006-11 ,pp. : 947-952

Springer Publishing Company

Access to resources Recommend Favorite